FP3, a Novel VEGF Blocker, Expressing Oncolytic Adenovirus Induces Potent Antiangiogenic and Antitumor Efficacy

被引:0
|
作者
Choi, Il-Kyu [1 ]
Shin, Hyewon [1 ]
Oh, Eonju [1 ]
Yoo, Ji Young [1 ]
Hwang, June Kyu [1 ]
Yu, De-Chao [2 ]
Yun, Chae-Ok [1 ]
机构
[1] Hanyang Univ, Coll Engn, Bioengn, Seoul 133791, South Korea
[2] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610064, Peoples R China
关键词
D O I
10.1016/S1525-0016(16)33937-5
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
328
引用
收藏
页码:S131 / S131
页数:1
相关论文
共 50 条
  • [41] Potent antitumor effect of neurotensin receptor-targeted oncolytic adenovirus co-expressing decorin and Wnt antagonist in an orthotopic pancreatic tumor model
    Na, Youjin
    Choi, Joung-Woo
    Kasala, Dayananda
    Hong, JinWoo
    Oh, Eonju
    Li, Yan
    Jung, Soo-Jung
    Kim, Sung Wan
    Yun, Chae-Ok
    JOURNAL OF CONTROLLED RELEASE, 2015, 220 : 766 - 782
  • [42] A Potent Oncolytic Adenovirus Selectively Blocks the STAT3 Signaling Pathway and Potentiates Cisplatin Antitumor Activity in Ovarian Cancer
    Han, Zhiqiang
    Hong, Zhenya
    Gao, Qinglei
    Chen, Caihong
    Hao, Zhou
    Ji, Teng
    Hu, Wencheng
    Yan, Yuting
    Feng, Jing
    Liao, Shujie
    Wu, Peng
    Wang, Daowen
    Wang, Shixuan
    Zhou, Jianfeng
    Ma, Ding
    HUMAN GENE THERAPY, 2012, 23 (01) : 32 - 45
  • [43] Novel, orally active multi-kinase inhibitors of c-MET and the VEGF receptor family exhibit potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Beaulieu, N
    Nguyen, H
    Beaulieu, C
    Dupont, I
    Barsalou, A
    Gravel, S
    Chute, I
    Robert, MF
    Lefebvre, S
    Dubay, M
    Rahil, J
    Claridge, S
    Raeppel, F
    Saavedra, O
    Bernstein, N
    Granger, MC
    Zhan, LJ
    Llewellyn, D
    Wal, A
    Deziel, R
    Besterman, J
    Wang, J
    Vaisburg, A
    MacLeod, AR
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9029S - 9030S
  • [44] Ang-2-VEGF-A CrossMab, a Novel Bispecific Human IgG1 Antibody Blocking VEGF-A and Ang-2 Functions Simultaneously, Mediates Potent Antitumor, Antiangiogenic, and Antimetastatic Efficacy
    Kienast, Yvonne
    Klein, Christian
    Scheuer, Werner
    Raemsch, Romi
    Lorenzon, Erica
    Bernicke, Dirk
    Herting, Frank
    Yu, Sidney
    Huynh Hung The
    Martarello, Laurent
    Gassner, Christian
    Stubenrauch, Kay-Gunnar
    Munro, Kate
    Augustin, Hellmut G.
    Thomas, Markus
    CLINICAL CANCER RESEARCH, 2013, 19 (24) : 6730 - 6740
  • [45] Enhanced Antitumor Efficacy of Integrin-targeted Oncolytic Adenovirus AxdAdB3-F/RGD on Bladder Cancer
    Wang, Hua
    Cai, Zhijian
    Yang, Fei
    Luo, Juan
    Satoh, Makoto
    Arai, Yoichi
    Li, Dechuan
    UROLOGY, 2014, 83 (02) : 508.e13 - 508.e19
  • [46] Intratumoral delivery of a novel oncolytic adenovirus encoding human antibody against PD-1 elicits enhanced antitumor efficacy
    Zhou, Ping
    Wang, Xuchen
    Xing, Man
    Yang, Xi
    Wu, Mangteng
    Shi, Hongyang
    Zhu, Caihong
    Wang, Xiang
    Guo, Yingying
    Tang, Shubing
    Huang, Zhong
    Zhou, Dongming
    MOLECULAR THERAPY-ONCOLYTICS, 2022, 25 : 236 - 248
  • [47] Enhanced Antitumor Efficacy of Oncolytic Adenovirus Co-Expressing IL-12 and shVEGF Combined with Anti-PD-1 in Renal Cell Carcinoma
    Kim, Yunlim
    Yoon, A-Rum
    Yun, Chae-Ok
    Kim, Choung-Soo
    Lim, Bumjin
    CANCER IMMUNOLOGY RESEARCH, 2024, 12 (10)
  • [48] Substitution of Adenovirus Serotype 3 Hexon onto a Serotype 5 Oncolytic Adenovirus Reduces Factor X Binding, Decreases Liver Tropism, and Improves Antitumor Efficacy
    Short, Joshua J.
    Rivera, Angel A.
    Wu, Hongju
    Walter, Mark R.
    Yamamoto, Masato
    Mathis, J. Michael
    Curiel, David T.
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (09) : 2536 - 2544
  • [50] Systemic Administration of Polymer-Coated Oncolytic Adenovirus Loaded into Human Mesenchymal Stromal Cells Induces Efficient Tumor Homing and Infiltration to Elicit Potent Antitumor Effect
    Thambi, Thavasyappan
    Na, Youjin
    Nam, Joung-Pyo
    Eonju, Oh
    Shin, Ha Cheol
    Kim, Hyun Su
    Kim, Sung Wan
    Yun, Chae-Ok
    MOLECULAR THERAPY, 2020, 28 (04) : 164 - 164